Rush Thomas S, Powers Robert
Structural Biology & Computational Chemistry, Department of Chemical & Screening Sciences, Wyeth Research, 87 Cambridge Park Dr. Cambridge, MA, 02140, USA.
Curr Top Med Chem. 2004;4(12):1311-27. doi: 10.2174/1568026043387999.
The following review discusses the successful application of X-ray, NMR, and molecular modeling in the design of potent and selective inhibitors of matrix metalloproteinases (MMPs) and TNFalpha-converting enzyme (TACE) from Wyeth. The importance of protein and ligand mobility as it impacts structure-based design is also discussed. The MMPs are an active target for a variety of diseases, including cancer and arthritis.
以下综述讨论了X射线、核磁共振(NMR)以及分子建模在辉瑞公司设计基质金属蛋白酶(MMPs)和肿瘤坏死因子α转换酶(TACE)强效选择性抑制剂方面的成功应用。还讨论了蛋白质和配体流动性对基于结构的药物设计的影响。MMPs是包括癌症和关节炎在内的多种疾病的有效靶点。